Analyst Ratings
Upgrades, downgrades, and price-target changes from Wall Street firms.
Get trade alerts by text
We text you when insiders, Congress or big funds make new trades. Free.
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.
Morgan Stanley Reiterates Overweight Rating on Guardant Health
Morgan Stanley has reiterated its Overweight rating on Guardant Health with a new price target of $200.
Truist Securities Maintains Buy Rating on Smurfit Westrock
Truist Securities has reiterated its Buy rating on Smurfit Westrock with a new price target of $54.
RBC Capital Maintains Outperform Rating on Smurfit Westrock
RBC Capital reaffirms its positive outlook on Smurfit Westrock with a price target reduction.
Mizuho Maintains Outperform Rating on Hubbell Incorporated (HUBB)
Mizuho has reiterated its Outperform rating on Hubbell, adjusting its price target down to $560 from $575.
Susquehanna Reiterates Positive Rating on Formula One Group
Susquehanna keeps its Positive rating on Formula One Group, lowering the price target to $110.
Canaccord Genuity Maintains Buy Rating on BioNTech SE
Canaccord Genuity has reiterated its Buy rating on BioNTech SE with a new price target of $132.
Barclays Reiterates Overweight Rating on PPL Corporation
Barclays maintains its Overweight rating on PPL Corporation with a new target of $38, while shares are currently below that level.
Barclays Reiterates Overweight Rating on Qnity Electronics, Inc.
Barclays maintains its bullish stance on Qnity Electronics with a target of $211.00.
Truist Securities Reiterates Buy Rating on Qnity Electronics
Truist Securities has reaffirmed its Buy rating on Qnity Electronics and set a price target of $170.
RBC Capital Reiterates Outperform Rating on Qnity Electronics
RBC Capital keeps a positive outlook on Qnity Electronics while adjusting its price target.
Truist Securities Maintains Buy Rating on CenterPoint Energy
Truist Securities reaffirms its Buy rating on CenterPoint Energy with a new price target of $44.00.
Keybanc Reiterates Overweight Rating on CenterPoint Energy
Keybanc maintains its Overweight rating on CenterPoint Energy with a price target of $44.00.
Citigroup Reiterates Buy Rating on Xylem Inc.
Citigroup has reaffirmed its Buy rating on Xylem, adjusting its price target to $148.0.
Barclays Reiterates Overweight Rating on Xylem Inc.
Barclays has maintained its Overweight rating on Xylem Inc. with a new price target of $139.0.
RBC Capital Reiterates Outperform Rating on Xylem Inc.
RBC Capital has reiterated its Outperform rating on Xylem with a revised price target of $135.0 as of October 14, 2026.
Oppenheimer Reiterates Outperform Rating on Xylem Inc.
Oppenheimer has reaffirmed its Outperform rating on Xylem with a price target of $150.
Mizuho Reiterates Outperform Rating on Dover Corporation
Mizuho maintains its Outperform rating and adjusts the price target for Dover Corporation to $245.
HC Wainwright Reiterates Buy Rating on Incyte Corporation
HC Wainwright has reiterated its Buy rating on Incyte Corporation with a price target of $152 as of October 13, 2026.
TD Cowen Maintains Buy Rating on West Pharmaceutical Services, Inc.
TD Cowen has reiterated its Buy rating for West Pharmaceutical Services with a new price target of $420.
Wells Fargo Maintains Underweight Rating on W. R. Berkley Corporation
Wells Fargo has reiterated its Underweight rating on W. R. Berkley, lowering the price target to $65.
Goldman Sachs Maintains Buy Rating on Affirm Holdings
Goldman Sachs has reaffirmed its Buy rating on Affirm Holdings, lowering the price target to $103.
Citigroup Reiterates Buy Rating on nVent Electric plc
Citigroup has maintained its Buy rating on nVent Electric, raising the price target to $228 on October 12, 2026.
RBC Capital Reiterates Outperform Rating on nVent Electric plc
RBC Capital has reiterated its Outperform rating on nVent Electric plc with a new price target of $208.
RBC Capital Reiterates Outperform Rating on F5, Inc.
RBC Capital maintains its Outperform rating on F5, Inc. with a new price target of $525.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.
SMS Terms
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.